triazoles has been researched along with Cancer of Kidney in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 10 (55.56) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Benedyk-Machaczka, M; Blø, M; Chen, TJ; Furriol, J; Gausdal, G; Kalucka, U; Kamińska, M; Lorens, J; Marti, HP; Mydel, P; Osman, T | 1 |
| Abdulwahab, HG; Al-Hussain, SA; Al-Qurashi, NT; Farghaly, TA; Muhammad, ZA; Zaki, MEA | 1 |
| Chen, XF; Chen, Z; Gu, DH; Sun, X; Zheng, B; Zhu, H; Zhu, WL | 1 |
| Gao, X; Jiang, G; Liu, D; Tao, D; Wang, L; Wu, X; Xiao, X; Xie, F; Zeng, F | 1 |
| Cai, GY; Chen, XM; He, JC; Hong, Q; Li, O; Wu, D; Xiao, WZ; Zhang, L; Zheng, W | 1 |
| Kim, S; Kubatka, P; Kwon, TK; Min, KJ; Park, JW; Seo, SU; Woo, SM | 1 |
| Camidge, DR; Ching, KA; Christensen, JG; Clark, JW; Diamond, JR; Eckhardt, SG; Kanteti, R; Lira, ME; LoRusso, PM; Salgia, R; Schoenmakers, EF; Varella-Garcia, M; Wilner, K; Xu, LG | 1 |
| Abdel-Aziz, M; Abuo-Rahma, Gel-D; Ali, TF; Beshr, EA | 1 |
| Toyokuni, S | 1 |
| Friedlander, S; Kauffman, M; Landesman, Y; Shacham, S; Weiss, RH; Wettersten, HI | 1 |
| Furukawa, S; Handa, H; Hashimoto, A; Hashimoto, S; Mikami, S; Oikawa, T; Okada, Y; Onodera, Y; Oya, M; Sabe, H; Sugino, H; Yoshikawa, A | 1 |
| Carter, JE; Culpepper, M; Goel, S; Kahn, AG | 1 |
| Alexandrou, P; Dimitroulis, D; Kostakis, A; Kykalos, S; Mantas, D | 1 |
| Evans, CP; Inoue, H; Kauffman, M; Landesman, Y; Shacham, S; Weiss, RH; Yang, J | 1 |
| Hollis, D; Mahoney, J; Ratain, MJ; Rini, B; Rosner, G; Small, E; Stadler, WM; Zaentz, SD | 1 |
| Dutcher, JP; Friedland, DM; Leon, L; Manola, J; Roth, B; Wilding, G | 1 |
| Bruntsch, U; Dodion, P; Hansen, HH; Hansen, M; Pinedo, HM; Renard, J; Ten Bokkel Huinink, WW; Van Glabbeke, M | 1 |
| Bremer, K; Donhujsen-Ant, R; Peukert, M; Possinger, K; Queisser, W; Wagner, H | 1 |
1 review(s) available for triazoles and Cancer of Kidney
| Article | Year |
|---|---|
Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis.
Topics: Adsorption; Animals; Asbestos; Asbestosis; Benzoates; Carcinogens, Environmental; Carcinoma, Renal Cell; Cell Transformation, Neoplastic; Comparative Genomic Hybridization; Deferasirox; Ferric Compounds; Ferric Oxide, Saccharated; Genes, p16; Glucaric Acid; Humans; Iron Chelating Agents; Iron Overload; Japan; Kidney Neoplasms; Male; Mesothelioma; Mineral Fibers; Peritoneal Neoplasms; Phlebotomy; Pleural Neoplasms; Rats; Triazoles | 2014 |
2 trial(s) available for triazoles and Cancer of Kidney
| Article | Year |
|---|---|
Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Renal Cell; Disease-Free Survival; Double-Blind Method; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Research Design; Survival Rate; Treatment Outcome; Triazoles | 2005 |
Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: E4896, an Eastern Cooperative Oncology Group Study.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Disease Progression; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Patient Selection; Time Factors; Treatment Outcome; Triazoles | 2005 |
15 other study(ies) available for triazoles and Cancer of Kidney
| Article | Year |
|---|---|
AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model.
Topics: Animals; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Disease Progression; Humans; Kidney Neoplasms; Mice; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor Protein-Tyrosine Kinases; Signal Transduction; Triazoles | 2021 |
Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity.
Topics: Acetophenones; Antineoplastic Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Indoles; Kidney Neoplasms; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship; Sunitinib; Triazoles; Vascular Endothelial Growth Factor Receptor-2 | 2020 |
Dual inhibition of DNA-PKcs and mTOR by CC-115 potently inhibits human renal cell carcinoma cell growth.
Topics: Animals; Carcinoma, Renal Cell; Cell Proliferation; DNA-Activated Protein Kinase; Female; Humans; Kidney Neoplasms; Mice; Pyrazines; TOR Serine-Threonine Kinases; Triazoles | 2020 |
Inhibition of BRD4 Suppresses Cell Proliferation and Induces Apoptosis in Renal Cell Carcinoma.
Topics: Animals; Apoptosis; Azepines; Carcinoma, Renal Cell; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Humans; Kidney Neoplasms; Mice, Nude; Neoplasm Proteins; Nuclear Proteins; Transcription Factors; Triazoles | 2017 |
LncRNA HOTAIR regulates HIF-1α/AXL signaling through inhibition of miR-217 in renal cell carcinoma.
Topics: Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Carcinoma, Renal Cell; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Neoplasms; Male; MicroRNAs; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; RNA, Long Noncoding; RNA, Neoplasm; Signal Transduction; Triazoles | 2017 |
Axl Inhibitor R428 Enhances TRAIL-Mediated Apoptosis Through Downregulation of c-FLIP and Survivin Expression in Renal Carcinoma.
Topics: Apoptosis; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Carcinoma, Renal Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Down-Regulation; Humans; Kidney Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Survivin; TNF-Related Apoptosis-Inducing Ligand; Triazoles | 2019 |
Initial clinical sensitivity and acquired resistance to MET inhibition in MET-mutated papillary renal cell carcinoma.
Topics: Antineoplastic Agents; Biopsy; Carcinoma, Renal Cell; Disease Progression; Drug Resistance, Neoplasm; Heterozygote; Humans; In Situ Hybridization, Fluorescence; Kidney Neoplasms; Male; Methionine; Middle Aged; Point Mutation; Proto-Oncogene Proteins c-met; Pyrazines; Receptor Protein-Tyrosine Kinases; Sequence Analysis, DNA; Threonine; Treatment Failure; Triazoles | 2013 |
New nitric oxide donating 1,2,4-triazole/oxime hybrids: synthesis, investigation of anti-inflammatory, ulceroginic liability and antiproliferative activities.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Line, Tumor; Edema; Humans; Kidney Neoplasms; Male; Nitric Oxide; Nitric Oxide Donors; Oximes; Rats; Stomach; Triazoles; Ulcer | 2013 |
Specific inhibition of the nuclear exporter exportin-1 attenuates kidney cancer growth.
Topics: Active Transport, Cell Nucleus; Administration, Oral; Animals; Apoptosis; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Drug Approval; Drug Resistance, Neoplasm; Epithelial Cells; Exportin 1 Protein; Humans; Hydrazines; Karyopherins; Kidney Neoplasms; Male; Mice, Nude; Receptors, Cytoplasmic and Nuclear; RNA, Small Interfering; Triazoles; United States; United States Food and Drug Administration; Xenograft Model Antitumor Assays | 2014 |
Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer.
Topics: ADP-Ribosylation Factor 6; ADP-Ribosylation Factors; Adult; Aged; Aged, 80 and over; Amides; Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Enzyme Inhibitors; Epithelial-Mesenchymal Transition; Female; GTP-Binding Protein alpha Subunits, G12-G13; Guanine Nucleotide Exchange Factors; HEK293 Cells; Humans; Immunohistochemistry; Indoles; Isoxazoles; Kidney Neoplasms; Lysophospholipids; Male; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Nerve Tissue Proteins; Propionates; Pyridines; Pyrroles; Receptors, Lysophosphatidic Acid; Signal Transduction; Sirolimus; Sunitinib; Triazoles | 2016 |
Primary renal zygomycotic infarction mimicking renal neoplasia in an immunocompetent patient.
Topics: Adrenalectomy; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Humans; Immunocompetence; Kidney Diseases; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole; Zygomycosis | 2009 |
A rare case of breast cancer metastasis.
Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Female; Humans; Kidney Neoplasms; Mastectomy, Modified Radical; Middle Aged; Nephrectomy; Nitriles; Triazoles | 2010 |
CRM1 blockade by selective inhibitors of nuclear export attenuates kidney cancer growth.
Topics: Acrylates; Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Disease Models, Animal; Exportin 1 Protein; Flow Cytometry; Humans; Immunoblotting; Immunohistochemistry; Karyopherins; Kidney Neoplasms; Male; Mice; Mice, Nude; Molecular Targeted Therapy; Neoplasm Transplantation; Random Allocation; Receptors, Cytoplasmic and Nuclear; Sensitivity and Specificity; Survival Rate; Triazoles; Tumor Burden | 2013 |
Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent--a phase II study of the EORTC early clinical trials group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Kidney Neoplasms; Leukopenia; Male; Middle Aged; Thrombocytopenia; Triazoles | 1986 |
Phase II trial of 1,2,4-triglycidylurazol in patients with metastasized renal cell carcinoma.
Topics: Adult; Aged; Carcinoma, Renal Cell; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Triazoles | 1987 |